| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |